ginsenoside rh2 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, H; He, X; Hu, X; Li, J; Lv, W; Pan, Y; Shi, R; Wu, A; Xu, C | 1 |
1 other study(ies) available for ginsenoside rh2 and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
EGFR-Targeted Liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative Breast Cancer Growth and Metastasis.
Topics: Cell Line, Tumor; ErbB Receptors; Ginsenosides; Humans; Liposomes; Triple Negative Breast Neoplasms | 2023 |